Scientists have uncovered a new weakness in harmful “zombie-like” cells that may help doctors fight cancer and age-related diseases more effectively in the future.
These cells, called senescent cells, stop dividing but refuse to die. Instead, they stay inside the body and continue causing damage over time. Researchers now believe they may have found a way to force these cells to destroy themselves.
The new research was carried out by scientists at the MRC Laboratory of Medical Sciences and Imperial College London. The findings were published in the journal Nature Cell Biology.
Senescent cells are sometimes called “zombie cells” because they are still alive even though they no longer function normally. In healthy situations, senescence can actually help the body.
When damaged cells stop dividing, it may prevent them from turning into cancer cells. This is one reason chemotherapy often pushes cancer cells into senescence. The treatment stops the cells from growing and spreading.
However, scientists have gradually realized there is another side to the story. Although senescent cells no longer multiply, they remain highly active.
They release large amounts of harmful chemicals and inflammatory substances into nearby tissue. These substances can damage surrounding healthy cells, encourage cancer to spread, and create an unhealthy immune response.
Researchers also believe senescent cells contribute to many diseases linked to aging. These include fibrosis, tissue damage, chronic inflammation, and possibly conditions involving the brain, lungs, and heart. As people grow older, more of these zombie-like cells accumulate inside the body.
Because of this, scientists around the world have become very interested in finding “senolytic” drugs. These are medicines designed to selectively kill senescent cells while leaving healthy cells unharmed.
In the new study, the research team searched for compounds that could target these dangerous cells. They tested around 10,000 different chemical compounds on both healthy cells and senescent cells.
This was a massive screening effort that took place with the help of experts from Imperial College London’s Department of Medicinal Chemistry.
The scientists focused on a special group of chemicals called covalent compounds. These compounds can permanently attach themselves to proteins inside cells. This gives researchers the ability to block proteins that were previously considered too difficult to target with medicine.
After examining thousands of compounds, the researchers narrowed the list down to four especially promising candidates. Surprisingly, three of the most effective compounds attacked the same protein, known as GPX4.
GPX4 acts like a protective shield inside senescent cells. It helps them survive extremely stressful conditions that would normally kill ordinary cells. The protein protects the cells from a process called ferroptosis.
Ferroptosis is a special type of cell death linked to iron and harmful molecules called reactive oxygen species. These dangerous molecules can damage cell membranes and trigger destruction inside the cell. Recent research has suggested that senescent cells may be especially vulnerable to ferroptosis.
To survive, senescent cells appear to produce unusually large amounts of GPX4. This protective protein helps them resist self-destruction even though the inside of the cell is already highly damaged.
One researcher compared the situation to a person taking painkillers while continuing to run on an injured ankle. The medication hides the symptoms temporarily, but the underlying damage remains.
When the scientists blocked GPX4 using the experimental compounds, the senescent cells lost their protective defense. Without GPX4, ferroptosis became unavoidable and the zombie-like cells died.
The researchers then tested the treatment in three different mouse models of cancer. The results were very encouraging. Removing the senescent cells reduced tumor size and improved survival in all three models.
Professor Jesus Gil, senior author of the study and head of the Senescence group at the MRC Laboratory of Medical Sciences, said the team now wants to better understand how the treatment interacts with the immune system.
Scientists are especially interested in whether removing senescent cells could help activate the “good” parts of the immune system, including T cells and natural killer cells, which help destroy cancer.
The researchers also hope to learn which cancer patients might benefit most from this approach. For example, some patients receiving chemotherapy may produce especially high levels of GPX4. In the future, doctors might combine GPX4-targeting drugs with chemotherapy or immunotherapy to improve treatment success.
The study is important because it focuses on a part of cancer biology that has often been overlooked. Traditional cancer treatments usually focus directly on rapidly dividing tumor cells. This new strategy instead targets the harmful environment created by senescent cells surrounding the tumor.
The findings also suggest the research may have applications beyond cancer. Because senescent cells are strongly linked to aging-related diseases, future treatments targeting these cells could potentially improve health during aging as well.
Still, there are important limitations to remember. The research was mainly performed in laboratory studies and animal models. More studies are needed before scientists know whether the approach is safe and effective in humans. It may take years before GPX4-targeting treatments become available for patients.
Even so, the discovery represents an exciting advance in the growing field of senescence research. Scientists increasingly believe that removing harmful zombie cells may become an important strategy for treating cancer and age-related disease in the future.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more health information, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Source: Imperial College London.
